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AbstrACt
Introduction Clinicians often struggle to recognise when 
palliative care patients are imminently dying (last 72 hours 
of life). A previous study identified the factors that expert 
palliative care doctors (with demonstrated prognostic 
skills) had used, to form a judgement about which patients 
were imminently dying. This protocol describes a study to 
evaluate whether an online training resource showing how 
experts weighted the importance of various symptoms and 
signs can teach medical students to formulate survival 
estimates for palliative care patients that are more similar 
to the experts’ estimates.
Methods and analysis This online double-blind 
randomised controlled trial will recruit at least 128 
students in the penultimate or final year of medical school 
in the UK. Participants are asked to review three series 
of vignettes describing patients referred to palliative care 
and provide an estimate about the probability (0%–100%) 
that each patient will die within 72 hours. After the first 
series, students randomised to the intervention arm are 
given access to an online training resource. All participants 
are asked to complete a second series of vignettes. After 
2 weeks, all participants are asked to complete a third 
series. The primary outcome will be the probability of 
death estimates (0%–100%) provided by students in the 
intervention and control arms for the second series of 
vignettes. Secondary outcomes include the maintenance 
effect at 2-week follow-up, weighting of individual 
symptoms and signs, and level of expertise (discrimination 
and consistency).
Ethics and dissemination Approval has been obtained 
from the UCL Research Ethics Committee (8675/002) and 
local approvals will be obtained as appropriate. Results 
will be published in peer-reviewed journals using an open 
access format and presented at academic conferences. We 
will also publicise our findings on the Marie Curie website.
trial registration number NCT03360812; Pre-results.
IntroduCtIon 
When living with an incurable disease that 
shortens life expectancy, many patients and 
their relatives wish to receive information 
on what the future might bring, including 
a time frame of the expected length of 
survival.1 2 Several reports on care near the 
end of life have highlighted that recognition 
of the dying phase in palliative care patients is 
inaccurate and that this can have a significant 
negative impact on patient care at the end of 
life.3–5 Being aware that death is imminent 
can help patients, families and professionals 
to engage in discussions about goals of care 
and make decisions about appropriate care 
and treatment, including hospice admission 
and starting end-of-life care plans.6 7 In addi-
tion, better prognostic awareness can shift 
patients’ preferences from aggressive life-pro-
longing treatments towards comfort-oriented 
care.7–10 It can also help patients and fami-
lies to make plans for the time remaining, 
and discuss practical issues such as estate 
management and funeral planning.7 For 
strengths and limitations of this study
 ► This is an evaluation of a novel training resource for 
improving prognostic skills in recognising palliative 
care patients who are imminently dying.
 ► A multicentre randomised controlled trial design has 
been used, with (partial) blinding of participants and 
researchers and including a follow-up to test for any 
maintenance effects.
 ► This study will provide evidence about whether an 
online training resource can influence how medical 
students make prognostic decisions in an exper-
imental setting, using a prognostic task that may 
lack some ecological validity since it relies on an 
online rather than a face-to-face assessment of pal-
liative care patients. Therefore, further testing of the 
intervention in routine medical education and as-
sessment of the accuracy of clinicians’ performance 
in real-world prognostic tasks will be required.
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families, information about imminent death can help to 
make decisions about how to look after their loved one, 
for example, deciding whether the patient can remain 
at home or deciding whether to stay overnight or invite 
other relatives to visit.7 
While some prognostic models are available, in daily 
clinical practice it is usually the responsibility of a clini-
cian to formulate a survival estimate.11 12 Making accu-
rate survival predictions is notoriously difficult, estimates 
are often overoptimistic and prognostic skills do not 
necessarily develop over time.13–15 Many doctors try to 
avoid prognostication and feel insufficiently prepared to 
perform this clinical task.16 The European Association 
for Palliative Care has recommended that training could 
improve the accuracy of clinicians’ survival estimates, 
but there was little evidence to support this recommen-
dation.17 Virtually no education or training resources are 
available to specifically improve prognostic skills and a 
better understanding of how clinicians formulate their 
predictions is crucial to develop such resources.
This study will describe and evaluate an intervention for 
predicting imminent death (ie, death within 72 hours). 
Given the current lack of training resources to improve 
prognostic performance, this study will, as a proof of prin-
ciple, focus on medical students who have limited clin-
ical experience so that any effects of the intervention are 
more likely to be detected.
the intervention
The development of the training resource was informed 
by social judgement theory, which assumes that judge-
ments (prognostic decisions) result from the integration 
of different types of information, known as ‘cues’.18 Judge-
ment analysis attempts to capture an expert’s ‘judgement 
policy’ using a multiple regression procedure to calculate 
the relative weights that the experts attach to different 
cues. In a previous study, we have used judgement anal-
ysis19 to identify the clinical cues (eg, breathing pattern 
and the presence of respiratory secretions) that expert 
clinicians use to formulate a prognosis of imminent 
death.20 The training resource will provide students with 
task information on how to use the most important cues 
when making prognostic decisions. Outside of the pallia-
tive care context this approach has been used successfully 
to train a variety of other student populations about how 
to make decisions more aligned to those of experts.21–24
Experts can be identified in several ways.25 In our 
previous study, expert palliative care doctors were selected 
based on the validity of their judgements.26 Palliative care 
doctors were asked to complete an online prognostic test 
consisting of a series of vignettes based on real cases and 
their prognostic estimates were compared against actual 
survival. The top 20% of performers were defined as 
‘experts’ and were invited to complete a second series of 
fictional vignettes. We will evaluate students’ prognostic 
performance by comparing students’ estimates against 
the estimates provided by the experts for the same series 
of fictional vignettes. In addition, to gain a fuller picture 
of the expertise as demonstrated by the students, we will 
assess the extent to which they are able to discriminate 
between patients with different severities of symptoms/
signs and to consistently make similar prognostic deci-
sions for patients with similar symptoms/signs.25 It is 
important to note however that high levels of discrimina-
tion and consistency do not guarantee accuracy,27 there-
fore these results will be evaluated in conjunction with 
the comparison of students’ estimates against the experts’ 
estimates.
In addition to assessing whether students are able to 
follow the expert judgement policy, a follow-up assess-
ment will be included where students are not given access 
to the training resource to assess whether they have 
learnt the policy. A relatively short interval of 2 weeks 
was chosen to minimise the risk of attrition, based on 
our experience with a previous study evaluating a similar 
training resource that showed 10% attrition at the 2-week 
follow-up, even though participants received a financial 
reward on completion.22
The training resource will be offered to study partici-
pants in an online format, which will enable easy access 
at the students’ convenience, regardless of geograph-
ical location.28–30 If the training material is found to be 
successful, the online format will enable widespread 
dissemination and facilitate easy updating and students 
will be able to re-access the information as and when 
required.28 31 Studies have indicated that e-learning in 
medical education, as a supplement to traditional ways 
of teaching, is perceived as acceptable and evaluated as 
useful by students.31 32
objectives
The aim of this trial is to evaluate whether an online 
training resource can teach medical students to model 
the prognostic decisions of expert palliative care doctors 
about which palliative care patients are likely to die within 
72 hours. This study will include:
 ► Assess if the probability of death estimates formulated 
by medical students become more similar to experts’ 
estimates after completing an online training resource 
(primary objective).
 ► Determine if any effect of the online training resource 
is maintained after 2 weeks.
 ► Evaluate if the online training resource changes the 
weighting of individual symptoms/signs, and whether 
the students’ judgement policies become more similar 
to the experts’ judgement policies.
 ► Assess if the online training resource improves the 
expertise of the medical students, in terms of the 
ability to discriminate between patients and be 
consistent in decisions.
trial design
This is an online multicentre double-blind randomised 
controlled trial involving an intervention arm that will 
receive an online training resource for prognostication 
and a control arm. Medical students will be randomised to 
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these two parallel arms using a 1:1 allocation ratio. Since 
this will be the first trial of an intervention to improve 
prognostic skills, the study is designed as a proof of prin-
ciple study, evaluating whether the training resource can 
influence how medical students make prognostic deci-
sions in an experimental setting.
MEthods And AnAlysIs
This protocol follows guidance from the SPIRIT 2013 
statement33 and the completed SPIRIT checklist is avail-
able as an online supplementary file.
study setting
This study will be conducted online using a purpose-
built study website hosted by University College London 
(UCL). The study will recruit students from up to 33 
medical schools in the UK, approved by the Medical 
Schools Council.34 As we are offering a financial incentive 
for participating, it is important to control the potential 
total number of participants. We will approach individual 
medical schools as needed until the sample size has been 
achieved.
Eligibility criteria
Eligible participants should (1) be over 18 years of age; 
(2) be enrolled on a registered medical course within the 
UK; (3) be in the penultimate or final year of the course; 
(4) have sufficient English language proficiency and 
(5) be willing and able to provide consent as indicated 
by taking part in the online study assessments. Students 
in the penultimate and final year are felt to have suffi-
cient knowledge to understand the terminology in the 
vignettes and will have had at least 1 year of clinical expe-
rience as part of their training. Recruitment strategies 
will be targeted at students in the penultimate and final 
year of participating medical schools to minimise the risk 
of non-eligible students taking part. Participants will be 
asked to confirm their eligibility.
Intervention
The intervention is a newly developed online training 
resource to improve the recognition of imminent death 
in palliative care patients. The content was based on a 
previous study in which we used judgement analysis19 
to identify the clinical cues that expert palliative care 
doctors use to formulate a prognosis of imminent death 
in terminally ill inpatients.20 Experts were presented 
Figure 1 Sample vignette.
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with 50 vignettes describing hypothetical palliative care 
patients (see figure 1 for a sample vignette). There were 
seven symptoms and signs (‘cues’) available in each 
vignette: (1) Palliative Performance Scale score35; (2) 
Richmond-Agitation Sedation Scale score36; (3) rate 
of decline in general condition; (4) breathing pattern; 
(5) respiratory secretions; (6) urine output and (7) 
peripheral cyanosis. The first four cues were the most 
heavily weighted in the decision-making process of the 
experts.26
Study participants will be presented with the same 
vignettes and cues that had been presented to the expert 
palliative care doctors in the previous study. The online 
training resource will educate the participants on how to 
use the cue information when formulating a prognosis 
of imminent death, providing a description of the four 
most important cues and, where possible, graphical infor-
mation for ease of understanding. The intervention will 
be implemented via the study website and should take 
approximately 15 min to complete.
data collection procedure and outcomes
The data collection procedure is shown in the study flow 
diagram in figure 2. After obtaining informed consent, 
participants will be asked a number of questions to obtain 
a description of the sample and enable subgroup anal-
yses. This includes demographic questions (age, gender, 
ethnicity), course detail (place of study, year of study) and 
palliative care experience (training, placements, experi-
ence, confidence). Participants are asked for their name 
and university email address (to be entered twice for vali-
dation). This will allow them to log out and return to the 
same place at a more convenient time, which is hoped 
to reduce attrition. It will also allow the research team to 
check whether participants are affiliated with the univer-
sities the study is recruiting from, to populate the certifi-
cate of participation, and to send out reminders and gift 
vouchers.
Participants will then be randomised to either the inter-
vention arm or control arm. Next, participants are given 
instructions, and are reminded to complete the study 
individually, in a quiet location, free from distraction at 
a time and place of their choosing. Following this, they 
will be able to complete a practice vignette to familiarise 
themselves with the online environment.
All participants will then be asked to review a first 
series of 40 vignettes. Each vignette will present a 
description of a patient (the stem), which is identical 
for each vignette, with seven cues that describe differing 
severities of symptoms or signs that vary between 
vignettes (see figure 1). Participants will be asked to 
provide a percentage estimate of the probability that 
the patient will die within 72 hours (0% means no 
chance of death and 100% means certain death). This 
series of 40 vignettes includes 30 vignettes presented 
in random order for each participant, followed by 
10 repeated vignettes, also in random order. These 
repeated vignettes are included to assess participants’ 
level of expertise, as measured by the discrimination 
and consistency of probability of death estimates.37 The 
order in which the seven cues are presented are also 
randomised per participant, to prevent order effects.
Participants in the intervention arm will then receive 
the online training resource, while participants assigned 
to the control group will not receive this additional infor-
mation but will be informed that they are approximately 
half way through the study. All participants will be asked 
to provide probability of death estimates for a further 
series of 26 vignettes (including six repeated vignettes), 
in the same format as the first series of vignettes. The 
participants in the intervention arm will be able to access 
the online training resource during this second series of 
vignettes should they wish to do so. It is estimated that it 
will take up to 45 min to complete the first and second 
series of vignettes.
Two weeks after completing the second series of 
vignettes, participants will be asked to repeat the second 
series of 26 vignettes, although they will not be informed 
that the cases are the same as those that they have previ-
ously completed. Again, the vignettes will be presented 
in random order to minimise the risk of participants 
remembering vignettes or the estimates they provided 
previously. Participants in the intervention arm will not 
be given access to the online training resource on this 
occasion. This will enable us to determine if the effect 
of the intervention has lasted over time. It is estimated 
that this assessment will take up to 15 min to complete.
All participants can log out from the study website 
and return at a later time, at any point through the trial. 
Participants will be sent a reminder email when the third 
series of vignettes is due and if they start but do not finish 
the study. Participants will have a 4-week time window 
to complete the first and second series of vignettes, 
and another 4-week time window to complete the third 
series of vignettes. The web-based system will track the 
time students spend on completing the vignettes and 
the online training resource, if applicable. To improve 
data quality, drop-down lists are used where possible and 
participants will not be able to move on to the next page 
if essential information is missing or if information has 
been entered in an incorrect format. The online environ-
ment will be piloted by the study team.
Primary outcome
The primary outcome will be the continuous proba-
bility of death estimates (0%–100%) provided from the 
students for the second series of vignettes.
Secondary outcomes
a. The maintenance effect will be measured by using the 
probability of death estimates as described for the pri-
mary outcome measure at the 2-week follow-up time 
point.
b. Cue weighting of the individual students will be com-
pared against that of the experts. When students 
provide a probability of death estimate they weigh 
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Figure 2 Study flow diagram.
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information or ‘cues’ from the vignette as part of the 
process. By asking students to make a number of de-
cisions on a series of vignettes in which cue values are 
varied, it is possible to model the weights assigned to 
the various cues.
c. The level of expertise will be assessed with the Cochran-
Weiss-Shanteau (CWS) index of expertise.25 The CWS 
index captures the degree of expertise demonstrat-
ed in a set of responses and consists of the ratio of 
discrimination to inconsistency.37 This will help us 
to understand if the participants become better at 
discriminating between patients after the interven-
tion, and if their prognostic decisions become more 
consistent.
sample size
A sample of 128 subjects (64 subjects in each group) is 
required to detect a medium effect size (Cohen’s d=0.5) 
between the intervention and control groups, assuming 
a common SD, 80% power and using a two-sample t-test 
at the 5% significance level. A medium effect size of 
0.5 is described as an effect that is likely to be visible.38 
Larger effect sizes were achieved in previous evaluation 
studies of similar online training resources by one of the 
members of our study team (PH).22–24 We estimate that 
it will be necessary to recruit approximately 183 subjects 
in order to obtain a final sample size of 128 participants 
with complete data sets for analysis. The anticipated 
30% drop-out rate (ie, participants who start but do not 
complete the task) has been estimated on the basis of 
previous similar studies by our own group. Recruitment 
will start from April 2018 and we anticipate to complete 
recruitment by the end of December 2018.
recruitment
Recruitment strategies will differ slightly between 
medical schools to comply with local ethical/gover-
nance requirements. These methods may include: (1) 
the palliative care lead at each participating medical 
school introducing the study to students; (2) the course 
leader or administrator at each participating medical 
school distributing an email to all penultimate and 
final year students and (3) advertising the study using 
newsletters, virtual notice boards and student associ-
ations. The study recruitment materials will show the 
link to the study website and the study email address for 
students to contact the study team.
randomisation and blinding procedures
Participant randomisation will be undertaken automati-
cally through the web-based system using a pre-generated 
randomisation list with a block size of 10. This list will be 
generated by a member of the study team who will not be 
involved in recruitment (CT), using computer-generated 
random numbers.
Researchers and participants will be blinded as far as 
possible. For data monitoring purposes, researchers will 
be able to check how many participants are randomised 
to each arm, but will be blinded to which arm will be the 
intervention arm. All other data that could reveal the 
allocation (eg, time taken to complete the intervention) 
will be concealed from the researchers who will be moni-
toring the data (NW and LO) and the statistician who 
will conduct the analysis (FR). The allocation will remain 
concealed until the statistician has completed the anal-
ysis. Participants will be partially blinded to the nature of 
the intervention and the randomised controlled design 
of the study to minimise attrition in the control group. 
Rather than telling participants that half will receive the 
intervention and half will not, we will inform students 
that they will receive an online training resource in one 
of two different formats.
Inducements for participation
As a gesture for the time taken to complete the study 
and to promote participant retention, participants will 
be offered a total of £30 gift vouchers for completing 
the study. Participants will be offered a £10 gift voucher 
for completing the first stage of the study and a £20 gift 
voucher for completing the 2-week follow-up. The study 
will be open for new participants until 64 complete 
cases are available in each group. When recruitment 
closes, students who have started the study will be able to 
complete the remaining assessments and will be eligible 
to receive the vouchers. Participants who complete the 
research will receive a certificate of completion that will 
add towards their academic portfolio. Taking part in the 
study will give each participant an opportunity to develop 
some of the clinical skills required to recognise dying 
palliative care patients. If the resource is found to be 
effective, then this could benefit future medical students 
and palliative care patients.
Patient and public involvement
We involved two medical students in the design of the 
study, to make sure the research design is appropriate 
for this population and the study documents are easy to 
understand. Two fourth-year medical students reviewed 
the recruitment documents and piloted the website, 
keeping track of how much time was needed to complete 
the study. Both students provided valuable comments, 
resulting in several changes in the recruitment email, 
advertisement material and participant information 
sheet. These changes mainly involved emphasising certain 
aspects of the study to make it more appealing to medical 
students. One of these students will also be involved in 
distributing recruitment emails.
statistical methods
Demographic characteristics, course detail and palli-
ative care experience will be summarised by treatment 
assigned and overall. As a result of the randomisation 
process, we expect the groups to be balanced. Categor-
ical data will be presented as numbers and percentages. 
Continuous data will either be described with mean and 
SD, or median and IQR, pending the distribution. We 
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will produce a Consolidated Standards of Reporting 
Trials flow diagram of all participants (http://www. 
consort- statement. org/).
In this proof of principle study, we are seeking to 
evaluate whether an online training resource can 
influence how medical students make prognostic deci-
sions in an experimental setting. Therefore, we will 
employ a per-protocol analysis where those partic-
ipants who do not complete all vignettes or violate 
the protocol (eg, putting the same answer for every 
vignette) will be removed from the analysis. To assess if 
the online training resource affected the probability of 
death estimates provided, we will calculate the degree 
of agreement between the study participants’ proba-
bility of death estimates for the first and second series 
of vignettes and the probability of death estimates 
obtained from the experts in our previous study. Suit-
able regression models will be fitted to estimate the 
effect of the intervention, comparing agreement with 
the experts for those who received it and those who 
did not. In addition to this, we will also visualise the 
degree of agreement in both groups for the first and 
seconds series of vignettes, using the Bland-Altman 
method.39
The maintenance of the study effect will be measured 
by repeating the primary outcome analysis with the esti-
mates from the 2-week follow-up time point. To assess 
whether the intervention altered the judgement policy of 
the participants, we will examine participants’ cue weights 
for the three series of vignettes and correlate them with 
the expert’s cue weights presented in the training infor-
mation. The CWS performance index and the subcom-
ponents discrimination and consistency will be compared 
between the intervention and control arms for the three 
series of vignettes.25 37
data monitoring and adverse events
Throughout the trial, the research team will review recruit-
ment figures. Researchers will check the responses given 
by the participants, and the time taken by each partici-
pant to complete the vignettes, to assess for compliance 
with the protocol. Participants may be excluded from the 
analysis if their response record strongly suggests that 
they did not comply with the study protocol (eg, all items 
answered with the same response or too speedily). The 
Trial Management Group (PS, PH, LO, NW, CT, SY, FR 
and HG) will be responsible for overseeing the trial and 
will meet regularly (at least four times per year) to review 
recruitment figures.
This is a very low risk study. Students will have had 
at least 1 year of clinical experience as part of their 
training, and are informed that the vignettes are hypo-
thetical. In the participant information sheet students 
are encouraged to contact the student support services 
at the medical school they attend if they do experience 
psychological distress. This study will not have a Data 
Monitoring Committee.
Ethics and dissemination
In case any protocol amendments are required, these 
will be reviewed by the Trial Management Group before 
submission to the relevant committees, and the trial 
registry will be informed where necessary.
Consent
Participants will be given a brief summary of what the 
study involves in the recruitment email. On the website, 
there will be a welcome page with information about the 
study and the participant information sheet is available 
to download. However, as described above, participants 
will be partially blinded to the nature of the intervention 
and the randomised controlled design of the study. The 
participants will be reminded that they are free to with-
draw at any time. Informed consent will be obtained via 
two checkboxes before starting the study assessments: (1) 
to participate and (2) to acknowledge the results will be 
used in future publications, research and educational 
packages. Those who do not consent will not be able to 
continue to the next page.
On completion of the second and third series of 
vignettes, a debrief page will be shown to remind the 
participant what the results will be used for. The contact 
details for the study team will also be displayed should 
they have any concerns or issues they wish to follow-up. 
This debrief will not include any more detailed expla-
nation of the two groups students were randomised to 
or the active intervention, as we feel this would not be 
appropriate. Students will participate at a time conve-
nient to them, and we would not want students who have 
completed the study to disclose this information to others 
who have yet to participate.
data management
Our study received ethics approval before the introduc-
tion of the General Data Protection Regulation (GDPR) 
on May 25th, 2018. The documents that were approved 
state that all data will be handled in accordance with the 
UK Data Protection Act 1998. No formal amendment was 
required following the introduction of the GDPR, but 
we added a transparency message to the study website to 
make participants aware of how we will use their informa-
tion. Participants will be asked for their names and univer-
sity email address as a personal identifier as well as being 
assigned a unique participant ID. During the trial, all data 
will be kept securely on a web-based database, which is 
encrypted and password protected. The database will be 
accessible to approved members of the research team 
only as access to the Intranet will be restricted to their 
IP addresses only. Recruitment strategies may include the 
study being introduced to students by their local palliative 
care lead. This person will not have access to the study 
database and will therefore not be aware which students 
participated and which did not, nor will he or she have 
access to the prognostic performance data of individual 
students.
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Once all data have been reviewed and the gift vouchers 
have been distributed, the names and email addresses will 
be deleted from the web-based database in a secure manner 
and only the participant ID will be referenced. The final 
trial database will be downloaded from the website by the 
research team for statistical analysis and UCL will act as the 
data controller of such data for the study.
dissemination policy
Study results will be published in peer-reviewed, indexed 
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